Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy

Author： Blumenfeld Zeev  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.11, Iss.8, 1996-08, pp. : 1620-1626

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome

By Kaltsas T  

Human Reproduction, Vol. 13, Iss. 1, 1998-01 ,pp. : 22-26

Oxford University Press

Access to resources Recommend Favorite

Endocrinology. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization

By Beckers N.G.M.  

Human Reproduction, Vol. 15, Iss. 1, 2000-01 ,pp. : 43-49

Oxford University Press

Access to resources Recommend Favorite

Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy

By Franke Henk   Smit Wim   Vermes I⋅tvan  

Gynecological Endocrinology, Vol. 20, Iss. 5, 2005-05 ,pp. : 274-278

Informa Healthcare

Access to resources Recommend Favorite

Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.

By Cheung A P   Lu J K   Chang R J  

Human Reproduction, Vol. 12, Iss. 6, 1997-06 ,pp. : 1156-1164

Oxford University Press

Access to resources Recommend Favorite

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

By Elgendy M   Afnan M  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2382-2385

Oxford University Press

Access to resources Recommend Favorite